CAT vs COCP · P/E 48, rev $37.96B vs rev $105.0K
Caterpillar Inc (CAT) versus Cocrystal Pharma Inc (COCP) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. COCP currently screens at market cap $13.3M.
Not investment advice. Open the CAT and COCP stock pages for the full models.
Not investment advice.